Introduction
============

The epidemic of acute Hepatitis C-virus infection (AHC) is an on-going issue, especially among MSM patients. Spontaneous HCV clearance rates have been estimated to be between 5-40%, with lower rates among HIV-1 co-infected patients. High rates of sustained virological response have been observed (60-80%) when patients are treated within 24 weeks of AHC diagnosis. Moreover, a spontaneous 2log reduction in HCV-RNA might be a good predictor of spontaneous HCV-RNA clearance in HIV-1 co-infected patients. The aim of this study is to analyse the incidence of 2-log-HCV-RNA spontaneous reduction in AHC in HIV-1 infected patients.

Materials and method
====================

We reviewed medical files of 930 HIV-1-infected patients from our Reference Centre. All patients diagnosed with AHC in 2010-2011 were included. Diagnosis of AHC was based on seroconversion and ALT elevation. HCV-RNA PCR data was collected at time of and on week 4 after diagnosis.

Results
=======

Eleven patients were included, but only 10 met our diagnostic criteria. One patient was excluded because of missing data. Demographic and clinical data are summarised in Table [1](#T1){ref-type="table"}. All patients were MSM. All but 2 patients had genotype 1a HC-virus. On week 4, 3 patients presented with a spontaneous 2log HCV-RNA reduction. All were diagnosed with genotype 1a AHC.

###### 

Demographic data (data shown in numbers (%) or median)

  Population                                
  ----------------------------------------- -------------------------------------
  Male sex                                  9 (100%)
  Age (median)                              44 y
  BMI (median)                              23
  Transmission risk-factor; MSM             9 (100%)
  Ethnicity (Caucasian/Black)               9 (100%)
                                            
  **HIV results**                           
                                            
  CD4-cells count (median)                  565
  HIV-RNA (copies/mL) (median)              \<37
  HAART+                                    9 (100%)
                                            
  **HCV**                                   
                                            
  Genotype 1a                               7 (78%)
  Genotype 4                                2 (22%)
  HCV-RNA To (copies/mL)                    1049740
  HCV-RNA T+4weeks (copies/mL)              552042
  \- 2 log at T+ 4w                         3 (33%)
  \- 2 log at T+ 4w according to genotype   3 (100%) genotype 1a / 0 genotype 4
                                            
  **Clinical features**                     
                                            
  AST (IU/L) T0 (median)                    357
  ALT (IU/L) T0 (median)                    654
  ALT (IU/L) T+4w (median)                  131

Conclusion
==========

Although completed on a small number of patients, this audit suggests that only a low proportion (33%) of HIV-1 infected patients presenting with AHC will meet a favourable 2log-HCV-RNA-drop criteria. This is slightly lower than rates reported by NEAT (i.e. 48%). It implies that these co-infected patients should benefit from a close follow-up in order to start treatment within 24 weeks of AHC diagnosis, whenever it is needed and available.
